P.B. receives grant funding from Novartis Institute of Biomedical Research and has received grant funding from Deerfield Therapeutics, both for unrelated projects. P.B. has also served on a paid advisory board for QED Therapeutics. E.R.M. serves on the supervisory board of Qiagen N.V., the board of directors for Singular Genomics Inc. and a paid advisory board for Scorpion Therapeutics LLC.